IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Clinical trials for IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES trials appear
Sign up with your email to follow new studies for IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) to target and attack faulty cells that drive autoimmune diseases like lupus and scleroderma. The therapy is given as a one-time infusion and aims to reset …
Matched conditions: IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug CC312 tested for tough autoimmune cases
Disease control Recruiting nowThis early study is testing the safety of a new drug, CC312, in 6 adults with lupus, myositis, or systemic sclerosis that has come back or not responded to standard treatments. Participants receive increasing doses of CC312 by IV to see if it is safe and tolerable. The goal is to…
Matched conditions: IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated May 12, 2026 13:41 UTC